Loading...
Synergistic Enhancement of Cellular Immune Responses by the Novel Toll Receptor 7/8 Agonist 3M 007 and Interferon-γ: Implications for Therapy of Cutaneous T-Cell Lymphoma
CTCL is responsive at all stages to immunotherapy. We determined whether a novel agonist for TLR 7/8 (3M007) combined with either IFN-γ or IL-15 enhanced patients' immune responses in vitro. Our data demonstrate synergism between IFN-γ and 007 in the activation of patients' NK cytolytic ac...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3612958/ https://ncbi.nlm.nih.gov/pubmed/21942329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.582202 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|